Clinical Trial Update: Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities [Phase 1, Phase 2]

View source ↗

Summary

A PK/safety study of atorvastatin in children with Kawasaki disease and coronary artery abnormalities has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of California, San Diego | Conditions: Kawasaki Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-04